8-KLeadership ChangesExhibits & Filings

Rocket Lab Corp 8-K Report, Executive Changes (Nov 9, 2021)

Filed November 9, 2021For Securities:RKLB

Summary

Rocket Lab USA, Inc. (RKLB) disclosed in its Form 8-K filed on November 9, 2021, the adoption of an Executive Severance Plan on November 3, 2021. This plan outlines the compensation and benefits provided to named executive officers in the event of specific employment terminations outside of a change in control period, as well as more substantial provisions during a change in control period. The plan aims to provide financial security and retention incentives for key personnel. The plan distinguishes between terminations by the company (other than for cause, death, or disability) or resignations for good reason. Outside of a change in control, executives receive a specified period of base salary and continued health insurance contributions. In the event of a change in control, the severance benefits are significantly enhanced, including lump-sum payments of base salary and target annual bonus, extended health insurance contributions, and accelerated vesting of equity awards. This structure suggests a strategic approach to executive compensation and retention, particularly in scenarios involving potential corporate transactions.

Key Highlights

  • 1Rocket Lab adopted an Executive Severance Plan for its named executive officers, effective November 3, 2021.
  • 2The plan provides severance benefits upon termination without cause, death, or disability, or resignation for good reason, outside of a change in control period.
  • 3Outside of a change in control, the CEO receives 12 months of base salary and health contributions, while Tier 2 officers receive 6 months.
  • 4During a change in control period, severance benefits are significantly enhanced, including lump-sum payments (150% of base salary and target bonus for CEO, 100% for Tier 2 officers) and extended health contributions.
  • 5In a change in control scenario, all outstanding and unvested time-based equity awards will fully vest, and performance-based awards will vest at target levels.
  • 6The plan includes provisions related to Section 280G of the Internal Revenue Code, potentially reducing payments if they would trigger excise taxes, to ensure a higher net after-tax benefit for the participant.
  • 7New forms of award agreements under the Company’s 2021 Stock Option and Incentive Plan were also approved for executive officers and non-employee directors.

Frequently Asked Questions

The primary purpose of the Executive Severance Plan is to provide financial security and incentivize retention for Rocket Lab's named executive officers. It outlines the compensation and benefits they will receive in the event of specific employment terminations, particularly in scenarios involving a change in control.

Severance benefits are significantly more generous during a change in control period. Outside of a change in control, executives receive a set number of months of base salary and health insurance continuation. During a change in control, they receive lump-sum payments (a percentage of base salary and target bonus), longer periods of health insurance continuation, and full acceleration of vesting for all equity awards (with performance awards vesting at target).

An executive is eligible for severance pay if their employment is terminated by the company other than for 'cause,' death, or 'disability,' or if the executive resigns for 'good reason.' The specific terms and benefits depend on whether the termination occurs within or outside of a defined 'change in control period.'

Yes, the plan acknowledges that payments made in connection with a change in control may not be eligible for a federal income tax deduction for the company under Section 280G of the Internal Revenue Code. It also notes that these payments may be subject to an excise tax for the participant under Section 4999. The plan includes a provision to reduce payments if such a reduction results in a higher net after-tax benefit to the participant.